Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
about
Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinomaMicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb proteinSurgical approach for hepatitis C virus-related hepatocellular carcinomaThe eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral InfectionsIntegrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survivalRole of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)The histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibitionN-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerClinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.Structural models of human eEF1A1 and eEF1A2 reveal two distinct surface clusters of sequence variation and potential differences in phosphorylation.c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinomaMYC Deregulation in Primary Human Cancers.Identification of drivers from cancer genome diversity in hepatocellular carcinoma.EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.Postnatal liver growth and regeneration are independent of c-myc in a mouse model of conditional hepatic c-myc deletionLong noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.Targeting c-Myc as a novel approach for hepatocellular carcinoma.Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients.Cirrhosis and Chronic Viral Hepatitis as Risk Factors for Hepatocellular Carcinoma: Romanian Single-clinic Experience.In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma.CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expressionDevelopment of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background.Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment.MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumorsMonocytes promote liver carcinogenesis in an oncogene-specific manner.Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis.Enhanced angiogenesis, hypoxia and neutrophil recruitment during Myc-induced liver tumorigenesis in zebrafishMolecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.Identification of genomic functional hotspots with copy number alteration in liver cancerMicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer.Accomplishments in 2008 in the management of hepatobiliary cancers.Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells.Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches.Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma.From global phosphoproteomics to individual proteins: the case of translation elongation factor eEF1A.
P2860
Q24298070-A02BA5BD-1187-4471-8033-D924EE69A78FQ24601263-B17B3E1A-96DF-474C-919E-70ECF4A7690DQ26824046-F523EBDF-86A1-4727-9B7A-B8180A392C64Q26825635-140C211E-2D0E-4811-96D6-0873EE3DEE0EQ28383106-908B5B4C-69E7-4D2D-BB99-519132ED1976Q28394917-23099FD0-A7AA-476E-82F7-3D639F7C4518Q28542639-F180CA82-9AA8-406D-B5F6-21E314C5AED8Q28771715-DE5929E5-0396-46BE-8131-E5E5E06D3EECQ30488297-429DA740-913F-4EC1-83E8-6B4CD53EC94EQ31043530-C33F351E-67F1-4BE5-870E-5A0ADC36F9D3Q33487694-3301DFD9-C9E8-444E-8F5F-C34383818CE4Q33608524-C6CABF17-A1F4-46CD-8A18-488547E717A7Q33661028-D8CE7FFB-320F-487F-8860-69AC4C4B8689Q33836755-CB731210-9E5D-4B08-8E8B-A033C3EB84EDQ33907993-32A60E51-3A87-4BA3-B1E6-EFD05AA6D328Q33970628-981C9F40-8C64-46CD-96EB-205922046B92Q34187598-9D2E056E-2FBF-4E95-8858-281BE57FF37CQ34376920-A415D111-72B9-4220-8AB8-E96241606922Q34391522-9BB0E0D3-4DA2-4F97-9493-5C24ACCD8A70Q34993975-69A05F22-475D-4486-BF16-9F324A84CD92Q35154758-DDCCDAE8-A0CC-45B3-9817-592B4139D96DQ35250612-AC1C642F-88D3-4D56-9D1C-DC38F7533918Q35338422-E496F2F1-A460-49DF-8244-3E5D39D45C28Q35741547-2C8EB886-5B55-40E1-8B63-5A9B700C6C39Q35907583-4B6DCD33-4900-4050-AB2A-E17813B5222CQ36165673-FCA575DD-2868-45C7-BD68-4CCC72B8998EQ36380197-86B60F77-4950-40BF-94BD-7132E7C80AF9Q36706259-3FE0F35A-3FF9-47EB-B40B-77D8EB853362Q36815029-DFFEA222-BA8E-4F56-B891-E865C25CF455Q37068706-2466FF75-D57E-47EB-A5FD-4397D4399926Q37097265-06BC734E-AEF4-40D4-A13C-AD7A44E81963Q37195560-480208D3-C142-4877-8F1F-BEDC4A20D482Q37295260-2109B70D-54E8-481B-98E5-A73BC243D554Q37323311-A29A3F7A-84C3-48C1-A504-CA28BDB19762Q37423734-91169D5B-16C3-49CF-876E-59EE4CAA6B7FQ37468851-FBE31474-3EFD-4C36-80FC-57559E1BAFE9Q37575126-205D016B-4320-4C2C-98EC-26D9C5E582ECQ37857056-D87BBFD6-0559-4683-A902-FCABEBA2DEF3Q37891167-C614E900-4D19-4692-A0B1-211D10FDC1C7Q37980245-DF11806B-7F02-43EE-A28C-DB9A24D5B4C9
P2860
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
@en
type
label
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
@en
prefLabel
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
@en
P2093
P50
P356
P1433
P1476
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
@en
P2093
Christof Schlaeger
Claudia Schiller
Grischa Toedt
Jörg Kleeff
Peter Bewerunge
Peter Schirmacher
Thomas Longerich
Volker Ehemann
P304
P356
10.1002/HEP.22033
P407
P577
2008-02-01T00:00:00Z